FIELD: medicine.
SUBSTANCE: erythropoetin is used for manufacture of medication for stimulation of accelerated structural tissue regeneration after hepatic resection in patient with benign and malignant tumours.
EFFECT: invention allows forming vascular net around resectional surface, restoring normal architecture of acinus, interacinal connective tissue, central veins and hepatic triads and achieving original sizes of liver.
3 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR NEOGENESIS | 2004 |
|
RU2542391C2 |
| PLASTER RELEASING ACTIVE COMPOUND | 2008 |
|
RU2463078C2 |
| RAPID PREPARATION AND USE OF ARTIFICIAL TISSUES AND FRAMES AS INDIVIDUAL IMPLANTS | 2009 |
|
RU2531046C2 |
| METHOD AND COMPOSITION FOR TISSUE REGENERATION USING STEM OR MARROW CELLS | 2009 |
|
RU2491076C2 |
| LOCAL APPLICATION AND ERYTHROPOIETIN PREPARATIONS FOR SKIN WOUND HEALING | 2008 |
|
RU2465003C2 |
| METHOD AND BIOREACTOR OF CULTIVATION AND STIMULATION OF THREE-DIMENSIONAL VIABLE CELL TRANSPLANTS RESISTANT TO MECHANICAL LOAD | 2004 |
|
RU2370534C2 |
| BIOREACTOR FOR CELL CULTIVATION | 2003 |
|
RU2332448C2 |
| THERAPEUTIC USE OF KERATINOCYTE GROWTH FACTOR | 1994 |
|
RU2146148C1 |
| COMPOSITION FOR CELL-REPLACEMENT THERAPY OF SOFT TISSUE DEFECTS | 2013 |
|
RU2522816C1 |
| METHOD FOR TREATING FROSTBITE USING MESENCHYMAL STEM CELLS ISOLATED FROM RED BONE MARROW | 2020 |
|
RU2748539C1 |
